Trump’s tariff threats send U.S. companies scrambling for lobbyists and loopholes
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
The Biden administration has recently announced its plans to lower the costs for 64 different drugs by implementing inflation penalties on drug manufacturers. This measure is part of an ongoing effort to make healthcare and prescription medications more affordable for Americans. The penalties would be applied to drugmakers in cases where the price of a drug increases faster than the rate of inflation.
The 64 drugs that will be affected by this policy include prevalent medications for conditions such as diabetes, high cholesterol, and asthma. This list of drugs represents nearly